Rubra Medicaments has informed that it enclosed Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2022.
The above information is a part of company’s filings submitted to BSE.